HIV (Human Immunodeficiency Virus) recombinant antigen, expression gene, expression vector and HIV detection kit
A technology for recombinant antigen and gene expression, which can be used in recombinant DNA technology, antibody mimics/scaffolds, and introduction of foreign genetic material using vectors, which can solve the problem of high risk of missed detection of HIV-O subtypes.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0067] Embodiment 1, the preparation of coated antigen and labeled antigen
[0068] Using genetic engineering technology, a large number of molecular biology analysis software analyzes and screens the gp41 protein of HIV-1, the gp41 protein of O subtype, and the dominant epitope gene segment of gp36 protein of HIV-2. The sequence is SEQ ID No. .1 (named HI), SEQ ID No.2 (named HII), SEQ ID No.3 (named O), design primers to amplify the target fragment, and perform point mutation on the HI fragment in order to improve the specificity of the kit. The mutation sites are HIV-1gp41T67A and D121E, and the sequence after mutation is named as HIA (SEQ ID No.4). The upstream primer of the HIA fragment has a BamHI site, the downstream primer has an EcoRI restriction site, the upstream primer of the HⅡ fragment has an EcoRI site, the downstream primer has a SalI restriction site, and the O fragment upstream primer has a SalI site, The downstream primer has an XhoI restriction site, the P...
Embodiment 2
[0072] Example 2, establishment of anti-human HIV-1 P24 hybridoma cell line and preparation of monoclonal antibody thereof
[0073] 1. Immunization of mice with recombinant P24 antigen
[0074] Dilute the P24 recombinant antigen (P24-Ag, Feipeng Biological Co., Ltd.) to 1.0 mg / mL, mix it with Freund's complete adjuvant (Sigma-Aldrich, product number: F5881) in equal volumes, and fully emulsify to obtain an oily emulsion . The emulsion was subcutaneously administered to the dorsal site of BALB / c mice (Guangdong Provincial Medical Experimental Animal Center: No. 119, Poyang Road, Huangqi, Nanhai, Foshan City, Guangdong Province, 6-week-old female, 5 mice) at a dose of 0.2 mL. Fourteen days after the first immunization, the intraperitoneal booster immunization was performed, that is, the same amount of antigen was mixed with an equal volume of Freund’s incomplete adjuvant (Sigma-Aldrich, F5506). The titer was determined by the method, if the titer is higher than 1:10000, it can...
Embodiment 3
[0097] Embodiment 3, the preparation and debugging of HIV detection kit
[0098] 1. Preparation of HRP-labeled antigen
[0099] Using NaIO 4 oxidation method. Weigh 8mg of horseradish peroxidase (HRP, British Biozyme laboratories company, article number: HRP4) and dissolve it in 0.4mL ultrapure water, then slowly add 20mg / mL NaIO freshly prepared in 0.4mL ultrapure water 4Solution, stirred gently at room temperature for 40 minutes in the dark, then added 48 μL of ethylene glycol (dissolve 8 μL of ethylene glycol in 40 μL of distilled water) solution, and stirred at room temperature for 40 minutes in the dark. Then immediately add 1 mL of the purified labeled antigen GST-HIA-HII-O obtained in Example 1 at 2 mg / mL, which was dialyzed against 20 mM, pH 9.51 carbonate buffer solution for 2 hours, and protected against light at 4°C to 20 mM, pH 9 .51 carbonate buffer dialyzed overnight. The next day, add 80 μL of freshly prepared 5 mg / mL NaBH dropwise to the mixture 4 solution...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com